Hikma Pharmaceuticals (MEX:HIKN) General and Admin. Expense: MXN10,420 Mil (TTM As of Dec. 2025)


MEX:HIKN Hikma Pharmaceuticals PLC MEX:HIKN
80 GF Score
Price MXN307.48
GF Value MXN409.59
! 5 Warning Signs
View Full Analysis

What is Hikma Pharmaceuticals General and Admin. Expense?

Hikma Pharmaceuticals MEX:HIKN 80 General and Admin. Expense is MXN10,420 Mil as of Dec. 2025. GuruFocus rates MEX:HIKN with a GF Score™ of 80/100 and a GF Value™ of MXN409.59. The stock has 5 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Hikma Pharmaceuticals's General and Admin. Expense for the six months ended in Dec. 2025 was MXN5,186 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was MXN10,420 Mil.

Hikma Pharmaceuticals General and Admin. Expense Related Terms

Hikma Pharmaceuticals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Hikma Pharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hikma Pharmaceuticals General and Admin. Expense Chart

Hikma Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,010.83 11,990.04 9,233.99 11,846.04 10,191.23

Hikma Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,820.69 5,129.63 6,006.44 5,234.52 5,185.64
MEX:HIKN
80GF Score
Hikma Pharmaceuticals PLC MEX:HIKN
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hikma Pharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN10,420 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of MXN10,420 Mil mean?
Hikma Pharmaceuticals (MEX:HIKN) has a General and Admin. Expense of MXN10,420 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Hikma Pharmaceuticals and its competitors.
Is Hikma Pharmaceuticals' General and Admin. Expense too high?
Hikma Pharmaceuticals' current General and Admin. Expense is MXN10,420 Mil. Overall, Hikma Pharmaceuticals has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Hikma Pharmaceuticals' General and Admin. Expense compare to ZTS and UTHR?
Hikma Pharmaceuticals' General and Admin. Expense of MXN10,420 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Hikma Pharmaceuticals and its competitors. Hikma Pharmaceuticals's current General and Admin. Expense is MXN10,420 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hikma Pharmaceuticals stock overvalued right now?
Hikma Pharmaceuticals (MEX:HIKN) has a current General and Admin. Expense of MXN10,420 Mil. The stock's GF Value™ is MXN409.59, compared to a current price of MXN307.48 — trading 24.9% below its estimated fair value. The current General and Admin. Expense is MXN10,420 Mil. Hikma Pharmaceuticals' overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Hikma Pharmaceuticals (MEX:HIKN), the current General and Admin. Expense is MXN10,420 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hikma Pharmaceuticals (MEX:HIKN) Overvalued in 2026?

Based on GuruFocus' analysis, Hikma Pharmaceuticals stock appears to be undervalued. The current stock price of MXN307.48 is trading 24.9% below its estimated GF Value™ of MXN409.59.

Key valuation signals for MEX:HIKN:

  • General and Admin. Expense: MXN10,420 Mil
  • GF Value™: MXN409.59 vs. price of MXN307.48 (24.9% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the MEX:HIKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hikma Pharmaceuticals Business Description

Address 10 Portman Square, London, GBR, W1H 6AZ
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.
80GF Score

Get the complete analysis for MEX:HIKN

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN307.48
Price
MXN409.59
GF Value